New treatment modalities for lung cancer, including targeted therapy and immunotherapy, have contributed to improved patient survival rates. However, these treatments come with unique adverse effects. The nurse’s role in managing symptoms of these adverse effects requires an understanding of treatment mechanisms of action and common side effects.